Enterprise League logo
Products

Myc Degraders | Ten63 Therapeutics

Product description

A novel therapeutic approach targeting Myc, a key driver of cancer development. These degraders eliminate Myc from cancer cells and the surrounding microenvironment, unleashing the immune system against notoriously hard-to-treat cancers.

Ten63 Therapeutics Logo

Ten63 Therapeutics

Durham, United States (US)


Price: N/A